“…In addition, some studies believe that vulnerable plaque will gradually increase in the late stage of atherosclerosis in some ACS patients, which will promote the increase of MMPs expression level in individual serum, further regulate more inflammatory factors, aggravate the individual inflammatory response, and increase the instability of vulnerable plaque (18)(19)(20). In addition, it has been proposed that the secretion of MMPs by fibroblasts is also affected by EMMPRIN, and the analysis of a large number of inflammatory diseases shows that the overexpression of EMMPRIN can significantly increase the expression level of individual MMPs (21,22). As a kind of chronic inflam-mation, the occurrence of atherosclerosis in patients with ACS is also affected by EMMPRIN, and some studies have found that, under the stimulation of inflammatory factors, the expression of EMMPRIN shows a gradual upward trend, and under this influence, the expression of MMPs in patients' serum also shows a rising trend (23,24).…”